Eligible mesothelioma patients are currently able to enroll in Phase II of a clinical trial at Columbia University to test the effectiveness of a combination of chemotherapy medications in treating malignant peritoneal or pleural mesothelioma.
The study will test a course of treatment combining the drugs oxaliplatin and gemcitabine in effort to treat tumors in patients [...]